Health Daily American Samoa: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Daily American Samoa.

Press releases published on June 17, 2026

Jun. 17, 2026

Ernexa Therapeutics Positioned to Become a Clinical-Stage Biotechnology Company as ERNA-101 On Track for Planned Q3 2026 IND Submission and First-in-Human Study

Indeterminate GlobeNewswire

Jun. 17, 2026

Ocular Therapeutix™ Investor Day to Highlight U.S. FDA Alignment on AXPAXLI™ NDA with Submission Planned for Fourth Quarter 2026

Indeterminate GlobeNewswire

Jun. 17, 2026

Gelteq Provides Corporate Update: Launching Veterinary and Human Clinical Trials, Pharmaceutical Pipeline Expanding Across Multiple Programs

Indeterminate GlobeNewswire

Jun. 17, 2026

TOMI Advances Toward NSF Certification to Address Multi-Billion-Dollar Pharmaceutical, Biotech and Cleanroom Decontamination Markets

Indeterminate GlobeNewswire

Jun. 17, 2026

Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery Platform

Indeterminate GlobeNewswire

Jun. 17, 2026

Avalyn Completes Target Enrollment in Phase 2b MIST Trial of AP01 (Inhaled Pirfenidone) for Patients with Progressive Pulmonary Fibrosis

Indeterminate GlobeNewswire

Jun. 17, 2026

Oncotelic Advances AI-Powered GMP Manufacturing Services Platform for Revenue-Generating AI and Robotics Manufacturing Services

Indeterminate GlobeNewswire

Jun. 17, 2026

Merakris Therapeutics Awarded U.S. Department of Veterans Affairs Federal Supply Schedule Contract, Expanding Federal Market Access for Dermacyte® AC Matrix Amniotic Membrane Allograft

Indeterminate GlobeNewswire

Jun. 17, 2026

Elicio Therapeutics Reports Multiple Complete Responses After ELI-002 7P Treatment and Subsequent Therapy with Checkpoint Inhibition in Metastatic mKRAS Pancreatic Cancer

Indeterminate GlobeNewswire

Jun. 17, 2026

electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference

Indeterminate GlobeNewswire

Jun. 17, 2026

Trevi Therapeutics Announces Upcoming June and July Event Schedule  

Indeterminate GlobeNewswire

Jun. 17, 2026

Dyne Therapeutics Announces Expanded Debt Facility of Up To $400 Million with Hercules Capital, Inc.

Indeterminate GlobeNewswire

Jun. 17, 2026

CorVel Launches Marketwise Repricing™ to Deliver Smarter, Market-Based Medical Cost Containment

Indeterminate GlobeNewswire

Jun. 17, 2026

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

Indeterminate GlobeNewswire

Jun. 17, 2026

Step Pharma advances dencatistat into phase 2 clinical trial for essential thrombocythaemia

Indeterminate GlobeNewswire

Jun. 17, 2026

HMNC Brain Health appoints Dr. Bjørn Grønning as Chief Medical Officer

Indeterminate GlobeNewswire

Jun. 17, 2026

Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy

Indeterminate GlobeNewswire

Jun. 17, 2026

BrewDog Turns Up Father’s Day Across the U.K. with Gift-Ready Beer, Custom Cans and Dads Eat Free

Indeterminate GlobeNewswire

Jun. 17, 2026

NexTel Medical Outlines its Revenue Model Using the Innovation of Tomorrow: Synergy of Advanced Medical Technologies and Massive Sales Infrastructure Primed to Drive Exponential Growth

Indeterminate GlobeNewswire

Jun. 17, 2026

Rezolute Highlights Results Presented from Natural History Outcomes Studies and its Ersodetug Clinical Program in Hyperinsulinism at Annual Meeting of the Endocrine Society

Indeterminate GlobeNewswire